Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Merlini

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Eye (London, England)|March 28, 2024
Programmed axon death: a promising target for treating retinal and optic nerve disordersAndrea Loreto, Elisa Merlini, Michael P Coleman
Trends in Neurosciences|December 2, 2021
Mitochondrial dysfunction as a trigger of programmed axon deathElisa Merlini, Michael P Coleman, Andrea Loreto
Medical Education|November 23, 2020
Social network dynamics throughout clinical training-Distance mattersLayla Badawy, Priyanka Oza, Rohan Shankarghatta, et al.
Neuroscience Research|January 19, 2023
NMN: The NAD precursor at the intersection between axon degeneration and anti-ageing therapiesAndrea Loreto, Christina Antoniou, Elisa Merlini, et al.
Molecular Neurobiology|October 1, 2024
Chronically Low NMNAT2 Expression Causes Sub-lethal SARM1 Activation and Altered Response to Nicotinamide Riboside in AxonsChristina Antoniou, Andrea Loreto, Jonathan Gilley, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2019
Dopamine neuron-derived IGF-1 controls dopamine neuron firing, skill learning, and explorationAlessandro Pristerà, Craig Blomeley, Emanuel Lopes, et al.
Iscience|February 24, 2022
SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolitesCarlo Angeletti, Adolfo Amici, Jonathan Gilley, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2022
Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domainHannah C Feldman, Elisa Merlini, Carlos Guijas, et al.
Elife|December 6, 2021
Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1Andrea Loreto, Carlo Angeletti, Weixi Gu, et al.
Neurobiology of Disease|June 5, 2025
SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotidesAndrea Loreto, Kaitlyn M L Cramb, Lucy A McDermott, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Eye (London, England)|March 28, 2024
Programmed axon death: a promising target for treating retinal and optic nerve disordersAndrea Loreto, Elisa Merlini, Michael P Coleman
Trends in Neurosciences|December 2, 2021
Mitochondrial dysfunction as a trigger of programmed axon deathElisa Merlini, Michael P Coleman, Andrea Loreto
Medical Education|November 23, 2020
Social network dynamics throughout clinical training-Distance mattersLayla Badawy, Priyanka Oza, Rohan Shankarghatta, et al.
Neuroscience Research|January 19, 2023
NMN: The NAD precursor at the intersection between axon degeneration and anti-ageing therapiesAndrea Loreto, Christina Antoniou, Elisa Merlini, et al.
Molecular Neurobiology|October 1, 2024
Chronically Low NMNAT2 Expression Causes Sub-lethal SARM1 Activation and Altered Response to Nicotinamide Riboside in AxonsChristina Antoniou, Andrea Loreto, Jonathan Gilley, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2019
Dopamine neuron-derived IGF-1 controls dopamine neuron firing, skill learning, and explorationAlessandro Pristerà, Craig Blomeley, Emanuel Lopes, et al.
Iscience|February 24, 2022
SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolitesCarlo Angeletti, Adolfo Amici, Jonathan Gilley, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2022
Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domainHannah C Feldman, Elisa Merlini, Carlos Guijas, et al.
Elife|December 6, 2021
Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1Andrea Loreto, Carlo Angeletti, Weixi Gu, et al.
Neurobiology of Disease|June 5, 2025
SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotidesAndrea Loreto, Kaitlyn M L Cramb, Lucy A McDermott, et al.
Pageof 1